FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Holley Danica		 2. Issuer Name and Ticker or Trading Symbol

THERALINK TECHNOLOGIES, INC. [ THER ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

9410 BILTMORE DRIVE		 3. Date of Earliest Transaction (MM/DD/YYYY)

6/15/2022
(Street)

SILVER SPRING, MD 20901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
8% Convertible Promissory Note $0.0048 6/15/2022  J (1)  $50000    6/29/2022 (2)6/1/2027 Common Stock 10504202 (3)$50000 $50000 D  
Warrants (right to buy) $0.0048 6/15/2022  J (4)  2100840    6/15/2022 6/1/2027 Common Stock 2100840 $0 (4)2100840 D  
Explanation of Responses:
(1) The Reporting Person purchased this promissory note from the corporation.
(2) The promissory note may be converted at the Reporting Person's election at any time following amendment to the corporation's articles of incorporation with the Secretary of State of the State of Nevada to increase the corporation's authorized stock to 100,000,000,000. This amendment to the corporation's articles of incorporation is expected to be filed on June 29, 2022. Additionally, the promissory note will automatically convert upon the listing or trading of common stock on a qualified national exchange.
(3) Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock.
(4) Granted to the Reporting Person as warrant coverage in connection with the convertible promissory note reported on this Table II.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Holley Danica
9410 BILTMORE DRIVE
SILVER SPRING, MD 20901		X
Signatures
/s/ Danica Holley6/22/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Theralink Technologies (CE) (USOTC:THER)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Theralink Technologies (CE) Charts.
Theralink Technologies (CE) (USOTC:THER)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Theralink Technologies (CE) Charts.